Patents Examined by Andrew Granston
  • Patent number: 5279966
    Abstract: This invention provides an isolated vertebrate nucleic acid molecule encoding F-spondin. This invention also provides a probe comprising a nucleic acid molecule of at least 15 nucleotides capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a F-spondin. This invention provides a host vector system for the production of a F-spondin. This invention provides purified F-spondin and the uses of compositions containing purified F-spondin. This invention further provides a method of attaching nerve cells to a matrix using purified F-spondin. This invention also provides a method of stimulating nerve cell growth using purified F-spondin. This invention further provides a method of regenerating nerve call using purified F-spondin. Finally, this invention provides a pharmaceutical composition for stimulating nerve cell growth comprising an effective amount of purified F-spondin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 2, 1992
    Date of Patent: January 18, 1994
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Thomas M. Jessell, Avihu Klar